Publications of Dirk Bumann
All genres
Journal Article (37)
2012
Journal Article
8 (10), e1002966 (2012)
Immunity to Intracellular Salmonella Depends on Surface-associated Antigens. PLoS Pathogens
Journal Article
7 (5), e35992 (2012)
Intestinal Inflammation Responds to Microbial Tissue Load Independent of Pathogen/Non-Pathogen Discrimination. PLoS ONE 2011
Journal Article
6 (6), e20749 (2011)
Salmonella-Induced Mucosal Lectin RegIII beta Kills Competing Gut Microbiota. PLoS ONE 2008
Journal Article
57 (8), pp. 1065 - 1072 (2008)
Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 2007
Journal Article
37 (9), pp. 2370 - 2377 (2007)
Identification and isolation of murine antigen-reactive T cells according to CD154 expression. European Journal of Immunology 2006
Journal Article
440 (7082), pp. 303 - 307 (2006)
Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature
Journal Article
74 (3), pp. 1649 - 1660 (2006)
Salmonella enterica highly expressed genes are disease specific. Infection and Immunity 2005
Journal Article
62 (3 Sp. Iss. Sp. Iss. SI), pp. 345 - 349 (2005)
Identification of Helicobacter pylori surface proteins by selective proteinase K digestion and antibody phage display. Journal of Microbiological Methods 2004
Journal Article
72 (11), pp. 6546 - 6553 (2004)
Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa. Infection and Immunity
Journal Article
72 (11), pp. 6738 - 6742 (2004)
Lack of stage-specific proteins in coccoid Helicobacter pylori cells. Infection and Immunity
Journal Article
4 (10), pp. 2843 - 2848 (2004)
Helicobacter pylori vaccine development based on combined subproteome analysis. PROTEOMICS
Journal Article
101 (23), pp. 8739 - 8744 (2004)
Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
22 (17-18), pp. 2273 - 2277 (2004)
Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 2003
Journal Article
71 (11), pp. 6320 - 6328 (2003)
Autodisplay: Efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains. Infection and Immunity
Journal Article
5 (12), pp. 1082 - 1095 (2003)
The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes and Infection
Journal Article
5 (12), pp. 1082 - 1095 (2003)
The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes and Infection
Journal Article
5 (12), pp. 1082 - 1095 (2003)
The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes and Infection
Journal Article
552 (2-3), pp. 110 - 114 (2003)
Rapidly maturing red fluorescent protein variants with strongly enhanced brightness in bacteria. FEBS Letters
Journal Article
37 (2-3), pp. 105 - 109 (2003)
T cell receptor-transgenic mouse models for studying cellular immune responses to Salmonella in vivo. FEMS Immunology and Medical Microbiology
Journal Article
2 (1/2), pp. 88 - 92 (2003)
Helicobacter vaccine development based on global approaches. Genome Letters